Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.91M Sell
14,851
-330
-2% -$38.6K 0.16% 75
2026
Q1
$1.83M Buy
15,181
+48
+0.3% +$5.54K 0.16% 72
2025
Q4
$1.59M Buy
15,133
+299
+2% +$28.1K 0.13% 80
2025
Q3
$1.25M Buy
14,834
+120
+0.8% +$9.88K 0.1% 104
2025
Q2
$1.16M Sell
14,714
-669
-4% -$53.2K 0.11% 97
2025
Q1
$1.38M Sell
15,383
-1,590
-9% -$148K 0.13% 85
2024
Q4
$1.69M Sell
16,973
-6,656
-28% -$686K 0.12% 89
2024
Q3
$2.68M Buy
23,629
+4,258
+22% +$506K 0.2% 49
2024
Q2
$2.4M Buy
19,371
+123
+0.6% +$15.8K 0.19% 53
2024
Q1
$2.54M Sell
19,248
-1,383
-7% -$170K 0.2% 53
2023
Q4
$2.25M Buy
+20,631
New +$2.14M 0.19% 59

Other funds holding MRK

Trust Point Inc's MRK Position: Q2 2026 in Review

Trust Point Inc reduced its Merck (MRK) stake by 2.2% in Q2 2026, selling an estimated $38.6K and leaving 14,851 shares worth $1.91M. The position accounts for 0.16% of the portfolio, ranked #75.

Trust Point Inc first reported a position in MRK in Q4 2023 and has held it in 11 quarters since. The position peaked at $2.68M in Q3 2024. 1,299 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Trust Point Inc held 14,851 shares of Merck worth $1.91M as of Q2 2026.
  • Trust Point Inc sold 330 Merck shares in Q2 2026, an estimated $38.6K.
  • Merck made up 0.16% of Trust Point Inc's portfolio in Q2 2026, its #75 holding.
  • Trust Point Inc first reported a position in Merck in Q4 2023 and has held it in 11 quarters since.
  • Trust Point Inc's Merck position peaked at $2.68M in Q3 2024.
  • 1,299 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Trust Point Inc's 13F filing for Q2 2026, filed 8 Jul 2026.